Valuation: Giant Biogene Holding Co., Ltd.

Capitalization 32.27B 36.14B 4.63B 3.94B 3.65B 3.41B 6.36B 426B 6.75B 41.75B 16.58B 201B 17.38B 17.02B 731B P/E ratio 2025 *
15.2x
P/E ratio 2026 * 12.7x
Enterprise value 26.29B 29.44B 3.78B 3.21B 2.98B 2.78B 5.18B 347B 5.5B 34.02B 13.5B 164B 14.16B 13.87B 596B EV / Sales 2025 *
4.44x
EV / Sales 2026 * 3.53x
Free-Float
42.68%
Yield 2025 *
3.67%
Yield 2026 * 3.9%
More valuation ratios * Estimated data
Dynamic Chart
1 day-2.01%
1 week-4.97%
Current month+2.28%
1 month-4.76%
3 months-17.38%
6 months-41.71%
Current year+2.28%
More quotes
1 week 33.8
Extreme 33.8
36.36
1 month 32.88
Extreme 32.88
38
Current year 32.88
Extreme 32.88
38
1 year 32.88
Extreme 32.88
87.1
3 years 28.4
Extreme 28.4
87.1
5 years 24.3
Extreme 24.3
87.1
10 years 24.3
Extreme 24.3
87.1
More quotes
Manager TitleAgeSince
Chief Executive Officer 59 21/04/2022
Director of Finance/CFO 39 21/04/2022
Corporate Secretary 30 01/10/2018
Director TitleAgeSince
Chairman 59 21/04/2022
Director/Board Member 55 30/11/2021
Director/Board Member 67 06/10/2022
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-2.01%-4.97%-37.20%-11.58% 4.63B
+0.86%+3.89%-9.63%+6.45% 349B
+1.00%+2.15%-5.91%+5.31% 146B
+0.99%+2.53%-1.42%+14.78% 69.85B
+0.79%+2.08%+3.78%-7.20% 67.78B
-1.51%+2.29%+46.91%-57.12% 42.41B
+0.28%+3.49%-14.22% - 34.1B
-1.70%-1.22%-22.84%-13.00% 24.98B
+1.75%-5.99%-8.29%-9.20% 19.38B
-0.45%+0.28%+8.31%+33.83% 13.81B
Average +0.00%+0.63%-4.05%-4.19% 77.21B
Weighted average by Cap. +0.64%+2.60%-4.34%+1.44%
See all sector performances

Financials

2025 *2026 *
Net sales 5.92B 6.63B 850M 723M 670M 626M 1.17B 78.1B 1.24B 7.66B 3.04B 36.87B 3.19B 3.12B 134B 7.18B 8.04B 1.03B 877M 813M 760M 1.42B 94.75B 1.5B 9.29B 3.69B 44.74B 3.87B 3.79B 163B
Net income 2.12B 2.37B 304M 259M 240M 224M 418M 27.95B 443M 2.74B 1.09B 13.2B 1.14B 1.12B 48.01B 2.53B 2.83B 363M 309M 286M 268M 499M 33.39B 529M 3.27B 1.3B 15.76B 1.36B 1.33B 57.34B
Net Debt -5.98B -6.7B -859M -731M -677M -633M -1.18B -78.92B -1.25B -7.74B -3.07B -37.26B -3.22B -3.16B -136B -6.9B -7.72B -991M -842M -781M -730M -1.36B -91.01B -1.44B -8.92B -3.54B -42.97B -3.71B -3.64B -156B
More financial data * Estimated data
Logo Giant Biogene Holding Co., Ltd.
Giant Biogene Holding Co Ltd is a China-based investment holding company. The Company is principally engaged the research, development, manufacture and sale of bioactive material-based beauty and health products through its subsidiaries. The Company's main products include functional skincare products and medical dressings, and they are produced with recombinant collagen as the key bioactive ingredient. The Company also develops and manufactures rare ginsenosides technology-based functional foods. The Company mainly conducts its businesses within the domestic market.
Employees
2,162
More about the company
Date Price Change Volume
23/01/26 34.04 $ -2.01% 7,353,508
22/01/26 34.74 $ -0.57% 2,697,705
21/01/26 34.94 $ -1.30% 4,744,294
20/01/26 35.40 $ +1.43% 5,343,850
19/01/26 34.90 $ -2.57% 5,896,450

Delayed Quote Hong Kong S.E., 23 January 2026 at 07:08 pm AEDT

More quotes
Trader
Investor
Global
Quality
ESG MSCI
BB
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
34.04HKD
Average target price
53.42HKD
Spread / Average Target
+56.92%
Consensus

Quarterly revenue - Rate of surprise